Nephrocare Health Services Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-10 Cr
QSept 2025
Quarterly Results

In Sept 2025, Nephrocare Health Services (NEPHROPLUS) reported revenue ₹250 Cr and net profit ₹-10 Cr. Compare with NEPHROPLUS fair value to assess whether the stock is under or overvalued.

NEPHROPLUS Quarterly Results — Revenue, Profit & EPS Highlights

Nephrocare Health Services latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore NEPHROPLUS share price data to track price trends across different timeframes.

  • Revenue of ₹250 Cr in Sept 2025 (+12.1% vs Mar 2025)
  • Net Profit of ₹-10 Cr in Sept 2025 (-140.0% vs Mar 2025)
  • EBITDA of ₹68 Cr in Sept 2025 (+23.6% vs Mar 2025)
  • Operating Margin of 26.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹-1.12 in Sept 2025 (-100.8% vs Mar 2025)

Nephrocare Health Services Quarterly Results — Revenue, EBITDA, Net Profit & EPS

NEPHROPLUS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Dec 2024 QoQ YoY
Revenue (₹ Cr) 250 223 234 263 203 12.1% -
Net Profit (₹ Cr) -10 25 24 32 20 - -
EBITDA (₹ Cr) 68 55 54 64 50 - -
EPS (₹) -1.12 140.89 13.10 3.43 2.47 - -
Operating Margin (%) 26.0% 23.0% 21.0% 23.0% 22.0% - -

NEPHROPLUS Share Price Trend — 1-Year Movement Across Quarterly Results

Nephrocare Health Services 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Nephrocare Health Services share price screener.

Profitability Ratios

Profit Margin -4.0%
EBITDA Margin 27.2%
Operating Margin 26.0%
ROE (Annual) -6.8%

Balance Sheet Highlights

Total Assets ₹997 Cr
Total Equity ₹584 Cr
Current Assets ₹545 Cr
Current Liabilities ₹129 Cr

Cash Flow Analysis

Operating Cash Flow ₹135 Cr
Investing Cash Flow ₹-125 Cr
Financing Cash Flow ₹54 Cr
Net Cash Flow ₹65 Cr

Current Market Data

Current Price ₹585.45
Exchange NSE
Last Updated May 21, 2026

NEPHROPLUS vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap

Nephrocare Health Services latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Apollo Hospitals
Sept 2025
₹115,322.48 Cr 8308.5 6,365 494 +12.4% - 7.8% 250.3
Max Healthcare Inst…
Sept 2025
₹102,188.91 Cr 1091.1 2,168 491 +10.8% - 22.6% 216.1
Fortis Healthcare
Sept 2025
₹72,751.54 Cr 967.3 2,381 329 +17.2% - 13.8% 227.1
Aster DM Healthcare
Mar 2026
₹39,048.19 Cr 759.3 1,219 154 -0.6% +18.1% 12.6% 279.1
Narayana Hrudayalaya
Sept 2025
₹37,624.87 Cr 1930.9 1,668 259 +11.0% - 15.5% 151.8
Sector Quarterly Performance Comparison
Healthcare Services sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores